Immune control of SIV in nonhuman primates: insights for HIV cure strategies
BACKGROUND: Despite the exceptional clinical results of antiretroviral therapy (ART) in reducing morbidity and mortality, HIV infection cannot be cured due to a pool of infected cells, mainly memory CD4 + T cells, that is established within weeks of initial infection and persists under ART; this virus reservoir causes rapid rebound of viral replication if ART is stopped. RECENT FINDINGS: The preclinical animal model of simian immunodeficiency virus (SIV) infection in rhesus macaques (RMs) recapitulates key features of HIV infection, pathogenesis, immunology, and persistence in humans, including early establishment and long-term survival of the virus reservoir and rapid viral recrudescence after ART interruption. The SIV infection model is fundamental for investigating biological mechanisms that, when specifically targeted, may reduce and eliminate the reservoir pool. PURPOSE OF REVIEW: The goal of this review is not to provide an overview of the most recent findings in HIV persistence. Instead, it focuses on three biological mechanisms of viral persistence that our team of investigators, as well as others in the field, have described and for which we are testing innovative targeted interventions to: preferentially kill infected CD4 + memory T cells by targeting intracellular mechanisms favoring their survival; induce a stronger and durable cytolytic response by CD8 + T cells, and eliminate the CD8 + T cell remodeling of CD4 + T cell metabolism that promotes viral latency.
Authors
- Guido Silvestri (ORCID: https://orcid.org/0000-0001-6602-2470)
- Barbara Cervasi
- Mirko Paiardini (ORCID: https://orcid.org/0000-0002-7276-3600)
Institutions
- Emory University (US)
Publication Details
- Journal
- Current Opinion in HIV and AIDS
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1097/coh.0000000000001096
- Primary Topic
- HIV Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00